The study identified several novel resistance mechanisms in Mycobacterium tuberculosis through genome-wide association studies, including new genes and mutations associated with resistance to various antimicrobials such as ethambutol, isoniazid, amikacin, kanamycin, ethionamide, levofloxacin, rifabutin, clofazimine, delamanid, and linezolid.